PR-203

N/A

Report date: 2025/12/10 14:38:35

Base Information

Drug NamePR-203
Drug Alias NamePR-203PR203
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Tumor necrosis factor superfamily member 15Anti-Interleukin-23
TargetsTumor necrosis factor superfamily member 15Interleukin-23
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Boan Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Boan Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A